Is Jeena Sikho Lifecare Ltd (JSLL) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Jeena Sikho Lifecare Ltd is a good quality company .

Is Jeena Sikho Lifecare Ltd (JSLL) undervalued or overvalued?

The key valuation ratios of Jeena Sikho Lifecare Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Jeena Sikho Lifecare Ltd (JSLL) share price return in the past 10 years?

Data is not available for this company

Is Jeena Sikho Lifecare Ltd (JSLL) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Jeena Sikho Lifecare Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

What is the share price of Jeena Sikho Lifecare Ltd (JSLL)?

Company share prices are keep on changing according to the market conditions. The current trading price of Jeena Sikho Lifecare Ltd (JSLL) on 17-Apr-2026 16:59:59 at 16:59 is 686.05.

What is the P/E ratio of Jeena Sikho Lifecare?

The latest standalone P/E ratio of Jeena Sikho Lifecare as of 17-Apr-2026 is 93.19.

What is the P/B ratio of Jeena Sikho Lifecare Ltd (JSLL)?

The latest standalone P/B ratio of Jeena Sikho Lifecare Ltd (JSLL) as of 17-Apr-2026 is 20.11.

What is the 52-week high and low of Jeena Sikho Lifecare Ltd (JSLL)?

The 52-week high of Jeena Sikho Lifecare Ltd (JSLL) is Rs. 850.00 and the 52-week low is Rs. 516.50.

Jeena Sikho Lifecare Ltd (JSLL) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Jeena Sikho Lifecare Ltd (JSLL)
Brand: Jeena Sikho Lifecare

Jeena Sikho Lifecare Ltd (JSLL) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 544476 NSE: JSLL | Trading | Small Cap

Key Metrics

Market Cap

₹8,455 Cr.

P/E Ratio

93.19

Price to Book (P/B)

20.11

Price to Sales (P/S)

18.02

EV/EBITDA

64.00

Return on Capital Employed (ROCE)

51.64%

Current Price

₹686.1

Return on Equity (ROE)

39.04%

Return on Assets (ROA)

33.06%

Operating Profit Margin

26.7%

Net Profit Margin

19.34%

Gross Profit Margin

27.9%

Book Value per Share

₹33.8

Sales Growth (YoY)

44.59%

Sales Growth (3 Years)

47.41%

Operating Profit Growth (1 Year)

34.75%

Operating Profit Growth (3 Years)

90.36%

Net Profit Growth (1 Year)

31.09%

52-Week Low / High

₹517 / 850

Net Profit Growth (3 Years)

100.41%

Dividend Yield

0.25%

Promoter Holding

63.62%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Jeena Sikho Lifecare Ltd?

Jeena Sikho Lifecare Ltd revenue growth is 44.6% for FY-2025 , which is above its 5 year CAGR of 37.8% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Jeena Sikho Lifecare Ltd?

Promoters hold 63.62% of the Jeena Sikho Lifecare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Jeena Sikho Lifecare Ltd vs industry peers?

Jeena Sikho Lifecare Ltd revenue CAGR is 37.80% , compared to the industry median CAGR of 0% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does Jeena Sikho Lifecare Ltd belong to?

Jeena Sikho Lifecare Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.

Q.1 Stock return of Jeena Sikho Lifecare Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of 31% based on the current price.

DeciZen - make an informed investing decision on Jeena Sikho Life

Based on:

Data

Overall Rating ⓘ
Login to view analysis.

1. Quality

2. Valuation

3. Price Trend

Jeena Sikho Lifecare stock performance

Key Ratios

Is Jeena Sikho Lifecare Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	40.1%	37.6%	50%	40.9%	53.3%	59.1%	51.6%	-
Value Creation Index ⓘ	2.0	1.8	2.7	1.9	2.8	3.2	2.7	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	106	94.4	136	146	204	324	469	469
Sales YoY Gr.	-	-10.8%	43.8%	7.8%	39.2%	59.1%	44.6%	-
Adj EPS ⓘ	0.7	0.7	1.1	1.2	2.7	5.5	7.1	7.3
YoY Gr.	-	-4.1%	62.9%	3.5%	127.1%	104.1%	30%	-
BVPS (₹) ⓘ	1	1.7	2.9	4	10.1	15.5	21.9	33.8
Adj Net Profit ⓘ	6	5.7	10.4	10.7	33.4	67.9	88.4	91
Cash Flow from Ops. ⓘ	1.3	11.7	17.5	17.5	17.2	36.7	68.6	-
Debt/CF from Ops. ⓘ	12	1.1	0.7	0.4	0.1	0	0.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	37.8%	47.4%	44.6%
Adj EPS ⓘ	NA	59%	82%	30%
BVPSⓘ	NA	67.2%	76%	41.8%
Share Price	-	-	30.6%	-69.8%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	75	52.7	55.1	35.4	41.1	42.7	38	26.2
Op. Profit Mgn % ⓘ	10	11.2	12.6	12.4	22.7	28.7	26.7	43
Net Profit Mgn % ⓘ	5.7	6.1	7.7	7.3	16.4	20.9	18.8	19.3
Debt to Equity ⓘ	2	0.9	0.5	0.2	0	0	0	-
Working Cap Days ⓘ	0	82	50	54	70	77	84	30
Cash Conv. Cycle ⓘ	0	26	21	20	20	30	51	17

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	7.3	2.7
TTM Sales (₹ Cr.)	469	205
BVPS (₹) ⓘ	33.8	0
Reserves (₹ Cr.) ⓘ	395	395
P/BV ⓘ	20.11	0.00
PE ⓘ	93.19	250.26

From the Market
52 Week Low / High (₹)	516.50 / 850.00
All Time Low / High (₹)	516.50 / 850.00
Market Cap (₹ Cr.)	8,455
Equity (₹ Cr.)	24.9
Face Value (₹)	2
Industry PE ⓘ	25.4

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Jeena Sikho Life - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	106	94	136	146	204	324	469
Operating Expenses ⓘ +	95	84	119	128	158	231	344
Manufacturing Costs	1	1	6	5	11	17	34
Material Costs	23	12	16	15	17	22	31
Employee Cost	14	22	30	34	43	66	100
Other Costs ⓘ	57	49	67	74	87	127	178
Operating Profit ⓘ	11	11	17	18	46	93	125
Operating Profit Margin (%)	10.0%	11.2%	12.5%	12.4%	22.7%	28.7%	26.7%
Other Income ⓘ +	0	1	1	1	2	6	6
Exceptional Items ⓘ	0	0	0	0	0	0	0
Interest ⓘ	1	2	1	1	1	0	1
Depreciation ⓘ	1	2	2	3	3	5	9
Profit Before Tax ⓘ	8	8	14	15	45	94	122
Tax ⓘ	2	2	4	4	11	25	31
Profit After Tax	6	6	10	11	34	69	91
PAT Margin (%)	5.7%	6.1%	7.6%	7.7%	16.6%	21.3%	19.3%
Adjusted EPS (₹)	0.7	0.7	1.2	1.2	2.7	5.6	7.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	8%	15%	15%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	8	14	24	37	126	192	273
Share Capital ⓘ	0	0	0	10	14	25	25
Reserves ⓘ	8	14	24	26	112	167	248
Debt +	16	12	12	7	1	0	10
Long Term Debt	1	0	0	1	1	0	0
Short Term Debt	15	12	12	6	0	0	10
Minority Interest	0	0	0	0	0	0	0
Trade Payables	8	6	3	5	6	4	9
Others Liabilities ⓘ	5	6	10	13	18	24	36
Total Liabilities ⓘ	36	38	49	62	151	221	328
Fixed Assets
Net Fixed Assets ⓘ +	13	17	23	28	60	67	153
Gross Block	14	20	28	37	71	82	177
Accumulated Depreciation	1	3	6	8	11	16	24
CWIP ⓘ	0	0	0	5	1	4	13
Investments ⓘ	0	0	0	0	5	4	4
Inventories	13	11	9	6	4	7	12
Trade Receivables	4	4	3	9	22	41	98
Cash Equivalents	1	1	9	3	32	62	26
Others Assets ⓘ	6	5	5	11	27	35	23
Total Assets ⓘ	36	38	49	62	151	221	328

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	1	12	18	17	17	37	69
PBT ⓘ	8	8	14	15	45	94	122
Adjustment ⓘ	2	4	4	3	2	-1	4
Changes in Working Capital ⓘ	-7	2	3	3	-21	-32	-24
Tax Paid ⓘ	-2	-2	-4	-4	-8	-25	-33
Cash Flow From Investing Activity ⓘ +	-11	-6	-8	-20	-57	-18	-70
Capex	-11	-6	-9	-13	-30	-14	-39
Net Investments	0	0	0	-0	-26	-13	-35
Others ⓘ	0	0	0	-6	-1	9	3
Cash Flow From Financing Activity ⓘ +	7	-5	-2	-5	48	-3	-1
Net Proceeds from Shares ⓘ	0	0	0	1	56	0	0
Net Proceeds from Borrowing ⓘ	1	-0	-0	1	-0	-0	0
Interest Paid ⓘ	-1	-2	-1	-1	-1	-0	-1
Dividend Paid ⓘ	0	0	0	0	0	-3	-10
Others ⓘ	7	-3	-0	-5	-6	-0	10
Net Cash Flow ⓘ	-2	1	8	-7	8	15	-2

Finance Ratio

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	74.94	52.7	54.64	37.26	41.57	43.52	39.04
ROCE (%)	40.13	37.58	50.01	40.89	53.31	59.08	51.64
Asset Turnover Ratio	2.94	2.55	3.12	2.65	1.92	1.75	1.71
PAT to CFO Conversion(x)	0.17	2	1.8	1.55	0.5	0.54	0.76
Working Capital Days
Receivable Days	15	17	10	15	28	36	54
Inventory Days	44	45	27	19	9	6	7
Payable Days	125	201	101	96	115	89	81

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Jeena Sikho Lifecare Ltd FAQs

The current trading price of Jeena Sikho Life on 17-Apr-2026 16:59 is ₹686.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Jeena Sikho Life stood at ₹8,454.9 Cr

The latest P/E ratio of Jeena Sikho Life as of 16-Apr-2026 is 93.19.

The latest P/B ratio of Jeena Sikho Life as of 16-Apr-2026 is 20.11.

The 52-week high of Jeena Sikho Life is ₹850.0 and the 52-week low is ₹516.5.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Jeena Sikho Life is ₹469 ( Cr.) .

About Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare is ayurvedic healthcare company headquartered in Zirakpur, Punjab. Founded by Manish Grover (popularly known as Acharya Manish) in the year 2017, the main motive of the company is to build a healthy India through preventive measures by providing authentic and good quality ayurvedic products.

Ayurveda is an alternative medical system with historical roots in Indian subcontinent. The origin of Ayurveda dates back to the Vedic era. It was developed more than 3,000 years ago in India. It is based on the belief that health and wellness depend on a delicate balance between the mind, body, and spirit. Its main goal is to promote good health, not fight disease. Ayurvedic theory states that all areas of life impact one's health, so it follows that the Vedas cover a wide variety of topics, including health and healthcare techniques, astrology, spirituality, government and politics, art, and human behavior.

Business area of the company

The company is a developing health care services providers in India. The company has portfolio of over a wide range of Ayurvedic products. The company also conducts various health checkup camps, yoga sessions to make people aware of their health problem.

Key events and milestones

2017: Incorporation of the company.
2018: Company came up with project i.e. Shuddhi Ayurveda.
2020: Company opened the first ayurvedic Panchkarma hospital in India.
2021: Company converted into Public Limited Company.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Jeena Sikho Lifecare Ltd (JSLL) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Jeena Sikho Life Share Price